Keyphrases
Antagonism
100%
Status Epilepticus
100%
Peripheral Inflammation
100%
Blood-brain Barrier
50%
Pilocarpine
50%
Blood-brain Barrier Disruption
37%
Systemic Inflammation
25%
Interleukin-1β
25%
Seizure
25%
Interleukin-1 Receptor Antagonist (IL-1Ra)
25%
Lithium Chloride
25%
Epilepsy
12%
T Cells
12%
Pathogenic Mechanism
12%
Lithium
12%
Intravenous Administration
12%
Mononuclear Cells
12%
EEG Activity
12%
Systemic Blood
12%
Barrier Mechanism
12%
Pilocarpine-induced Epilepsy
12%
Lithium-pilocarpine Model
12%
Osmotic Disruption
12%
Systemic Damage
12%
Pharmacology, Toxicology and Pharmaceutical Science
Epileptic State
100%
Inflammation
100%
Blood-Brain Barrier
87%
Pilocarpine
62%
Receptor Antagonist
25%
Cholinergic Receptor Stimulating Agent
12%
Pilocarpine-Induced Seizure
12%
Neuroscience
Status Epilepticus
100%
Blood Brain Barrier
87%
Pilocarpine
75%
Receptor Antagonist
25%
Cholinergic
12%
Cofactor
12%
T Cell
12%